Skip to search formSkip to main contentSkip to account menu

SR 142948A

Known as: SR-142948A 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
There is evidence to suggest that neurotensin (NT) may enhance cognitive function. The present study, therefore, examined the… 
Highly Cited
2005
Highly Cited
2005
Studies showing psychostimulant-like effects of exogenous neurotensin (NT) infused into the ventral tegmental area (VTA) prompted… 
2005
2005
Dopamine receptor agonist and NMDA receptor antagonist activation of the mesolimbic dopamine system increases locomotion and… 
2004
2004
Antipsychotic drugs (APDs) have previously been shown to alter Fos expression in a regionally specific manner. Increases in Fos… 
2002
2002
Abstract. The neuropeptide neurotensin (NT) exerts a wide range of central and peripheral effects. In particular, ejection of NT… 
2001
2001
SR‐142948A belongs to the second generation of potent, selective, non‐peptide antagonists of neurotensin receptors. It was used… 
Highly Cited
1997
Highly Cited
1997
SR 142948A, 2-[[5-(2,6-dimethoxyphenyl)-1-(4-(N-(3-dimethylaminopropyl)-N-methylc arbamoyl)-2-isopropylphenyl)-1H-pyrazole3…